tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with neuromedin b in 1 studies
Studies (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Trials (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Recent Studies (post-2010) (tyrosyl-isoleucyl-glycyl-seryl-arginine) | Studies (neuromedin b) | Trials (neuromedin b) | Recent Studies (post-2010) (neuromedin b) |
---|---|---|---|---|---|
111 | 0 | 29 | 252 | 2 | 56 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, WE; Harriott, P; McFerran, NV; Nelson, J; Scott, WN; Walker, B; Wilson, DJ | 1 |
1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and neuromedin b
Article | Year |
---|---|
Murine epidermal growth factor peptide (33-42) binds to a YIGSR-specific laminin receptor on both tumor and endothelial cells.
Topics: Amino Acid Sequence; Animals; Binding Sites; Breast Neoplasms; Cattle; Cell Adhesion; Cell Line; Chick Embryo; Endothelium, Vascular; Epidermal Growth Factor; Female; Humans; Mice; Models, Molecular; Molecular Sequence Data; Neurokinin B; Oligopeptides; Peptide Fragments; Receptors, Laminin; Tumor Cells, Cultured | 1996 |